Psych Pharm

After initiation or increase in dose of a selective serotonin receptor inhibitor (SSRI) such as escitalopram (Lexapro), the patient should be monitored for:

Hyperthermia, akathisia and clonus

Patients with diabetes who are receiving beta-blockers for the treatment of panic disorder should be monitored for:

Hypoglycemia

A side effect NOT associated with the use of suvorexant (Belsomra) is:

Hypogonadism

While on selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression, patients should be monitored for:

Hyponatremia

A beta-blocker used for the treatment of panic disorders could worsen:

depression

Atomonetine (Strattera) is indicated in the treatment of:

Attention deficit/hyperactivity disorder

Citalopram (Celexa) is approved for the treatment of:

Depression

A patient has been receiving a monoamine oxidase inhibitor (MAOI). How long before a selective serotonin receptor inhibitor (SSRI) can be initiated?

14 days

The brand name for escitalopram, used in the treatment of depression is

Lexapro

Patients at the highest risk of developing suicidal thoughts with the initiation of selective serotonin reuptake inhibitors (SSRIs) fall within the age range of:

18-24 years

The time to reach peak serum concentration of immediate-release preparations of guanfacine (Tenex), used in the treatment of attention deficit disorder, is approximately:

2.5 hours

Varenicline (Chantix) does NOT need to be discontinued for the occurrence of:

Abnormal dreams

For the initial treatment of alcohol dependency, naltrexone (Vivitrol) should be continued for at least:

3 months after cessation of drinking

Zolpidem (Ambien) is an appropriate short-term treatment of insomnia in a:

50-year-old diabetic with sleep onset insomnia

Duloxetine (Cymbalta), a serotonin norepinephrine reuptake inhibitor (SNRI), would NOT be recommended for a:

50-year-old with major depressive disorder and alcohol abuse

If taking a twice daily preparation of methylphenidate (Ritalin) or other stimulant for the treatment of attention deficit disorder, the patient should be advised to take the afternoon dose no later than:

6 pm

Suvorexant (Belsomra) for the treatment of insomnia would be most appropriately prescribed for a:

70-year-old with sleep onset insomnia

A side effect NOT associated with the use of zolpidem (Ambien) is:

Abnormal dreams

Ramelteon (Rozerem) for the treatment of insomnia induces sleep by:

Activating melatonin receptors

Fluoxetine (Prozac) is NOT approved as monotherapy for the treatment of:

Bipolar depression

Patients should be cautioned against abruptly discontinuing serotonin-norepinephrine reuptake inhibitors (SNRIs), such as venlafaxine (Effexor), because they may experience:

Discontinuation syndrome

When switching a patient from the immediate release guanfacine (Tenex) 1 mg by mouth 3 times daily for the treatment of ADD, to the extended release guanfacine the NP should:

Discontinue guanfacine (Tenex) then begin Intuniv at the lowest dose and titrate upward weekly.

Patients with insomnia should be advised to take zolpidem (Ambien)

Immediately before bed with at least 7-8 hours to sleep

Non-benzodiazepine hypnotic agonists for the treatment of insomnia induce sleep by:

Raising the levels of gamma-aminobutyric acid (GABA).

First-generation antipsychotic agents are also called neuroleptics because they:

Reduce agitation and normalize psychomotor activity

Serotonin-norepinephrine reuptake inhibitors (SNRIs), such as venlafaxine (Effexor):

Should be administered with food to minimize nausea

Ramelteon (Rozerem), a melatonin receptor agonist:

Should be used with caution in patients with liver disease

Laboratory monitoring for patients receiving serotonin-norepinephrine reuptake inhibitors (SNRIs) would NOT include:

Zolpidem

The generic name for Ambien to treat insomnia is:

Zolpidem

Venlafaxine (Effexor), a serotonin norepinephrine reuptake inhibitor (SNRI), is approved for the treatment of:

generalized anxiety disorder

The mechanism of action of second-generation antipsychotic medications such as aripiprazole (Abilify) does NOT include:

serotonin reuptake stimulation

In the treatment of post-traumatic stress disorder, the medication class that should generally be avoided is:

tricyclic antidepressants.

The main difference between first-and second-generation antipsychotics is:

Decreased extrapyramidal side effects

Which medication is NOT approved for the treatment of insomnia?

Amitriptyline (Elavil)

The most appropriate treatment for a patient diagnosed with severe anorexia nervosa with delusional symptoms is:

An atypical antipsychotic 2nd generation

Quetiapine (Seroquel) should NOT be prescribed during:

Dementia related psychosis in an older adult

Escitalopram (Lexapro) is approved for the treatment of:

Depression and generalized anxiety disorder

The generic name for Intuniv, used in the treatment of attention deficit disorder, is:

Guanfacine

The drug of choice for the treatment of attention deficit disorder in children and adolescents who are overaroused and easily frustrated is:

Guanfacine (Intuniv)

In the treatment of depression, the mechanism of action of fluoxetine (Prozac) is to:

Increase serotonin availability in the synaptic space, causing a downregulation of 5HT1A receptors.

A beta-blocker used for the treatmThe generic name of Abilify is:

Aripiprazole

The generic name of Abilify is:

Aripiprazole

Drug-drug interactions that may lead to serotonin syndrome would NOT be potentiated by the concomitant use of serotonin-norepinephrine reuptake inhibitors (SNRIs) and:

Aspirin

In the treatment of depression, the mechanism of action of bupropion (Wellbutrin) is to:

Inhibit the reuptake of norepinephrine and dopamine

The mechanism of action of venlafaxine (Effexor) in the treatment of depression is to:

Inhibit the reuptake of serotonin and norepinephrine

Before initiating doxepin (Silenor) for the treatment of insomnia, the nurse practitioner should assure that the patient is not taking a (n):

MAO inhibitor

Naltrexone (vivitrol) is indicated for treatment of addiction to:

Alcohol

Guanfacine (Intuniv), used in the treatment of attention deficit disorder, is classified as a (n)

Alpha 2 adrenergic agonist

Which of the following is NOT a brand name of methylphenidate?

Adderall

Follow up of children treated for attention deficit disorder who display a less than 40% reduction in core symptoms would NOT include evaluation for:

Adherence to elimination diets

When initiating bupropion hydrochloride (Zyban), patients should be informed to stop smoking:

After 7 days and continue therapy for up to 12 weeks

The drug of choice for the treatment of attention deficit disorder in an adolescent with a history of substance abuse is.

Atomoxetine (Strattera)

Which medication is NOT a stimulant used in the management of attention deficit disorder?

Atomoxetine (Strattera)

Quetiapine (Seroquel) is considered a (n):

Atypical antipsychotic, 2nd generation.

Suvorexant (Belsomra), used in the treatment of insomnia, induces sleep by:

Blocking the signals of orexin chemicals in the hypothalamus

Prior to initiation of serotonin- norepinephrine reuptake inhibitors (SNRIs) and routinely thereafter, monitoring should include:

Blood pressure

Following a dose increase in atomoxetine (Strattera), the nurse practitioner should check:

Blood pressure and pulse

Paroxetine (Paxil) is NOT approved for the treatment of:

Bulimia nervosa

If methylphenidate is contraindicated, which of the following medications is recommended for the treatment of ADHD in an adult?

Bupropion (Wellbutrin)

Prior to the initiation of atomoxetine (Strattera) for the treatment of attention deficit disorder, patients should be carefully evaluated for:

Cardiac disease

Prior to initiation of pharmacotherapy for the treatment of attention deficit disorder in adolescents, the LEAST important measure to assess is:

Complete blood count and comprehensive metabolic panel

Patients taking guanfacine (Intuniv) should be advised to take the medication:

Consistently, without abrupt cessation of medication

A patient who was started on guanfacine (Intuniv) returns to clinic with complaints of drowsiness during class. The nurse practitioner should

Decrease the dose of the medication and slowly taper up to desired dose.

A patient who is receiving naltrexone (Vivitrol) for alcohol abuse disorder requires oral surgery with anticipated opioid use for pain control. The naltrexone should be:

Discontinued at least 72 hours prior to surgery and resumed when opioids are no longer required

Ramelteon (Rozerem), a melatonin receptor agonist:

Does not cause physical dependence

First-generation antipsychotics, such as haloperidol (Haldol), reduce dopaminergic neurotransmission by blocking:

Dopamine D2 receptors

Patients receiving selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression should be advised to take the medication:

For a minimum of 6 months and to avoid abruptly stopping the medication

Therapeutic drug levels and predictably of clinical response are difficult to determine in first generation antipsychotics because they:

Have variable bioavailability, are lipophilic and highly protein bound

Routine monitoring of children receives atomoxetine (Strattera) for the treatment of attention deficit disorder includes:

Height and weight

Duloxetine (Cymbalta) should be avoided in patients with:

Hepatic impairment

For the treatment of insomnia, patients should be advised to take ramelteon (Rozerem)

Immediately before bed with at least 7-8 hours to sleep.

The mechanism of action of amitriptyline (Elavil), a tricyclic antidepressant, is to:

Increase norepinephrine and serotonin levels and block the action of acetylcholine

It is safe for patients on monoamine oxidase inhibitors (MAOIs), used in the treatment of depression, to consume:

Small amounts of white wine

Temazepam (Restoril), a benzodiazepine hypnotic agent:

Is a controlled substance

The use of selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression in older adults:

Is associated with falls and fractures

Buspirone (BuSpar), an anxiolytic,:

Is excreted by the kidneys

Which of the following is NOT a true statement about treatment of ADHD with methylphenidate (Ritalin)?

It may improve symptoms of depression

Prior to prescribing naltrexone (Vivitrol) for the treatment of opioid dependency, and periodically thereafter, the patient should be carefully monitored for:

Liver toxicity

Bupropion hydrochloride (Zyban) used for smoking cessation:

May cause hypertension and blood pressure should be monitored

The first line agent recommended in the treatment of attention deficit disorder in children and adolescents is:

Methylphenidate (Ritalin)

Which statement about naltrexone (Vivitrol) is correct?

Naltrexone does not cause physical dependence

In addition to attention deficit disorder, methylphenidate (Ritalin) is indicated in the treatment of:

Narcolepsy

The most commonly reported side effect of desvenlafaxine (Pristiq) is:

Nausea

The most commonly reported side effects of desvenlafaxine (Pristiq) are:

Nausea and dizziness

The drug class that is considered the first line option for the treatment of insomnia with the least possible side effects is:

Non-benzodiazepine hypnotics

Selective serotonin receptor inhibitors (SSRIs), such as citalopram (Celexa), are not likely to cause:

Pancreatitis

Sertraline (Zoloft) is approved for the treatment of:

Panic disorder

The brand name for desvenlafaxine is:

Pristiq

Caution should be advised when taking zolpidem (Ambien) combined with

Promethazine (Phenergan).

The best medication choice for controlling performance/speaking anxiety is:

Propranolol (Inderal)

Naltrexone (Vivitrol) does NOT affect alcohol addiction by:

Reducing the physical effects caused by alcohol

The brand name of temazepam is:

Restoril

Which statement is NOT true about selective serotonin reuptake inhibitors (SSRIs), such as escitalopram (Lexapro)?

SSRIs have a significant side effect profile due to a high affinity for non-serotonin receptors.

Bupropion (Wellbutrin), used in the treatment of depression, should NOT be administered to a patient with:

Seizure disorder

The mechanism of action of atomoxetine (Strattera), used in the treatment of attention deficit disorder, is to:

Selectively inhibit norepinephrine reuptake

The brand name for atomoxetine, used in the treatment of attention deficit disorder is:

Strattera

A potential side effect of atomoxetine (Strattera) for the treatment of attention deficit disorder is:

Suicidality

First-generation antipsychotics (e.g. haloperidol (Haldol)) are associated with side effects including:

Tardive dyskinesia

Use of methylphenidate (Ritalin) for ADHD in children can result in:

Tics

Fluvoxamine (Luvox) is approved for the treatment of:

obsessive compulsive disorder